Home › Hemophilia
Pag-aaral pangklinika para sa Hemophilia na nagre-recruit sa U.S.
28 pag-aaral para sa Hemophilia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Indianapolis, IN9 pag-aaral
- Los Angeles, CA7 pag-aaral
- Seattle, WA6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- Philadelphia, PA5 pag-aaral
- Sacramento, CA4 pag-aaral
- Tampa, FL4 pag-aaral
- Atlanta, GA4 pag-aaral
- Little Rock, AR4 pag-aaral
- Dallas, TX4 pag-aaral
- Greenville, NC4 pag-aaral
- Orange, CA4 pag-aaral
- San Francisco, CA3 pag-aaral
- San Antonio, TX3 pag-aaral
- St. Louis, MO3 pag-aaral
- Chicago, IL3 pag-aaral
- Detroit, MI3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Boston, MA3 pag-aaral
- Harrisburg, PA3 pag-aaral
- Kansas City, MO3 pag-aaral
- Aurora, CO3 pag-aaral
Ayos sa estado
- Arkansas4 pag-aaral
- California14 pag-aaral
- Colorado3 pag-aaral
- Florida6 pag-aaral
- Georgia4 pag-aaral
- Illinois4 pag-aaral
- Indiana9 pag-aaral
- Iowa6 pag-aaral
- Massachusetts3 pag-aaral
- Michigan5 pag-aaral
- Missouri5 pag-aaral
- New York4 pag-aaral
- North Carolina6 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania6 pag-aaral
- Texas8 pag-aaral
- Washington6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 2, 2026 · NCT05568719TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Nagre-recruitObservasyonal na pag-aaral
6 Months · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07692217Treatment of Hemophilia A Patients With FVIII Inhibitors
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kalalakihan · Na-update Set 23, 2026 · NCT04023019A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07416526A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Nagre-recruitPhase 3
Edad 1 hanggang 17 · Kalalakihan · Na-update Set 23, 2026 · NCT05611801A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Nagre-recruitPhase 4
Edad 12 pataas · Kalalakihan · Na-update Set 23, 2026 · NCT06145373A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Kalalakihan · Na-update Set 18, 2026 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Nagre-recruitPhase 1/2
Edad 2 hanggang 59 · Kalalakihan · Na-update Set 11, 2026 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2026 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07416604SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT04563520Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 20 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Nagre-recruitPhase 3
Edad 1 hanggang 11 · Kalalakihan · Na-update Ago 17, 2026 · NCT07285460Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Nagre-recruitObservasyonal na pag-aaral
Edad 6 hanggang 19 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Nagre-recruitPhase 3
Edad 1 hanggang 74 · Kalalakihan · Na-update Hul 1, 2026 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Nagre-recruitPhase 1
Edad 12 hanggang 74 · Kalalakihan · Na-update Hun 3, 2026 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT03695978Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Nagre-recruitPhase 4
Edad 12 pataas · Kababaihan · Na-update May 12, 2026 · NCT05936580Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Nagre-recruitPhase 4
Edad 12 pataas · Kalalakihan · Na-update May 12, 2026 · NCT05935358ATHNdataset Registry
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Nagre-recruitPhase 1
Edad 0 hanggang 90 · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT05500807Hemophilia A Research Program
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT07414511SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Nagre-recruitPhase 4
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT04647227Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.